Nabumetone
Product Images NDC 66336-316

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 66336-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Nabumetone (5276f530 14bc 492d 974b 913fd06bf52e 01)

FDA Label Image

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)
COOH and CH40 are not recognizable text and may contain errors or non-English characters. 6-methoxy-2-naphthylacetic acid (6MNA) is a chemical compound that belongs to the class of naphthalenes. It is an acetic acid derivative that contains a naphthalene ring system and a methoxy group at position 6. It is commonly used as an anti-inflammatory and analgesic agent in the treatment of various disorders, including osteoarthritis, rheumatoid arthritis, and menstrual pain.*
FDA Label Image

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)

FDA Label Image

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)
This is a graph showing the plasma concentrations of the active metabolite of Nabumetone (6MNA) at steady state following once-daily dosing of either 1000 mg (n=31) or 2000 mg (n=12) of Nabumetone. The x-axis represents the time in hours and the y-axis represents the plasma concentration in ng/mL. The graph displays two lines for each dosage, displaying the 2SD and +2SD for 1000mg and the 2SD for 2000mg respectively.*
FDA Label Image

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)
This is a report on the distribution of different forms of nabumetone metabolites in a sample, expressed as a percentage of total dose. The sample contained several forms of 6-methoxy-2-naphthylacetic acid (6MNA), 6-hydroxy-2-naphthylacetic acid (6HNA), and 4-(6-hydroxy-2-naphthyl)-butan-2-ol, in both conjugated and unchanged form. Additionally, there was an unidentified minor metabolite present. The percentage of each individual form of metabolites varied, with the majority of the sample being in the conjugated form of 6HNA.*
FDA Label Image

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)
This table shows the Mean/Mode Duration of treatment for patients with RA who are taking different doses of Nabumetone over a period of years. The results are reported in milligrams (mg) with varying number of patients for each dose.*
FDA Label Image

Side Effects Table (5276f530 14bc 492d 974b 913fd06bf52e 07)

Side Effects Table (5276f530 14bc 492d 974b 913fd06bf52e 07)
This text provides a list of serious and other side effects associated with the use of a medication. The serious side effects listed include heart attack, stroke, high blood pressure, kidney failure, liver failure, and life-threatening skin and allergic reactions. Other possible side effects include stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.*
FDA Label Image

Get Emergency Help If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 08)

Get Emergency Help If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 08)
This text describes different symptoms that could be related to a medical emergency or condition. These symptoms include shortness of breath or trouble breathing, slurred speech, chest pain, swelling of the face or throat, and weakness in one part or side of your body. It's important to seek medical attention if you experience any of these symptoms.*
FDA Label Image

Stop Nsaid If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 09)

Stop Nsaid If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 09)
This text appears to be a list of symptoms that may indicate potential medical problems. Symptoms listed include nausea, fatigue, itching, yellowing of skin or eyes, stomach pain, flu-like symptoms, vomiting blood, blood in bowel movements or black, tar-like appearance of bowel movements, unusual weight gain, skin rash or blisters with fever, and swelling of arms, legs, hands and feet. These symptoms may be indicative of serious medical conditions, and medical attention should be sought if experiencing any of them.*
FDA Label Image

Nsaid Medications That Need A Prescription (5276f530 14bc 492d 974b 913fd06bf52e 10)

Nsaid Medications That Need A Prescription (5276f530 14bc 492d 974b 913fd06bf52e 10)
This text provides a list of generic names and their corresponding trade names of various pain-relieving medications such as Celebrex, Cataflam, Voltaren, Dolobid, Lodine, Nalfon, Ansaid, and others.*
FDA Label Image

Glenmark Logo (5276f530 14bc 492d 974b 913fd06bf52e 11)

FDA Label Image

Ndc 66336-0316-xx (Ndc 66336 0316 Xx Invagen)

Ndc 66336-0316-xx (Ndc 66336 0316 Xx      Invagen)
This is a description of bulk source data for Nabumetone 500mg tablets. The manufacturer's name is Invagen Pharmaceuticals, and the product is identified with a white, oval-shaped, film-coated biconvex tablet debossed with IG/257. The bulk source NDC is 68462-0358-05, and the manufacturer's lot is 00000. The product should be dispensed in a tight/light-resistant container and taken orally every few hours as needed with food but avoiding alcohol. The text includes warnings about avoiding the reach of children, storing at 68°- 77° F, and potential side effects such as dizziness. The medication guide should be included in dispensing. The package was exclusively by VTS Solutions in Santa Ana, CA with an expiration date of 00-00 and RX number 23829272.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.